Anti-NMDA receptor encephalitis is a recently described autoimmune disease. The acute clinical features have been well-documented, but the long-term cognitive impact is poorly characterized. Now, Finke et al. have examined nine patients with this disorder, 23–69 months after disease onset. All but one of the patients displayed substantial cognitive impairments, particularly in executive functions and memory.